XGenomes Corp

XGenomes Corp is a biotechnology company based in Cambridge, Massachusetts, founded in 2017.

The company specializes in innovative DNA sequencing technology that reads DNA in "words" rather than individual letters. This method allows for faster, more accurate, and cost-effective analysis of unamplified single DNA molecules. XGenomes integrates advanced biochemistry, super-resolution fluorescence imaging, and machine learning to sequence DNA directly, eliminating the need for library preparation and complex bioinformatics. The company's core technology features OneBox systems designed for streamlined sample preparation and high-accuracy sequencing. XGenomes aims to make multi-omic information accessible for health monitoring, early disease detection, and precision medicine. With a focus on high-value customers in healthcare and research, XGenomes operates on a business model that begins with service access and transitions to selling instruments and consumables. The company is positioned to address the limitations of traditional sequencing methods, targeting applications in biotech and life sciences for lifelong genomic monitoring.